Ongoing Support After Injections Matters One of the biggest mistakes patients make is assuming their care ends with their last injection
From inaccurate calorie tracking and metabolic adaptation to water retention, hormonal fluctuations, and underlying medical conditions, this article explains the key causes, when to seek medical advice, and what NHS-supported options are available to help you manage your weight safely and effectively
Purified Water
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
What should a prescriber review before prescribing oral hypoglycemic agents
Needless to say, this is a topic the researchers tackled
